In this second part of their discussion, Dr. Dana Hartl sits down with Dr. Zubair Baloch for a practical conversation on what actually makes thyroid FNA cytology reliable. The episode challenges common assumptions about “adequate” sampling and why that single step quietly shapes every diagnosis that follows. They also tease how molecular testing and AI can help, and when they can mislead, if the fundamentals are not right.
Categories


